Abstract
Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have